Newsroom

Newsroom

A novel cross-site analysis of Vectra® Polaris™ multiplex fluorescence PD-1/PD-L1 immunohistochemistry on colorectal cancer with high and low microsatellite instability

Literature
Read More

NeoGenomics Appoints Dave Daly to Its Board of Directors

Press Release
Read More

NeoGenomics Announces Leadership Team Transition

Press Release
Read More

NeoGenomics Reports Revenue of $121 Million in the Third Quarter

Press Release
Read More

Talking Cancer: Conversations with Trailblazers, Advocates, Patients, and Medical Ambassadors

Blog
Read More

Detection of PAX5 Overexpression By RNA-Seq for B-Cell Lineage Detection in Acute Lymphocytic Leukemia

Literature
Read More

Use of Receptor Occupancy Assays on Cells from Peripheral Blood As a Model to Determine Therapeutic Efficacy

Literature
Read More

Enabling Precision Medicine for Breast Cancer Patients

Blog
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients